- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin-Associated Renal Dysfunction: Where Are We Now?
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 34, Issue 12, Pages 1259-1268
Publisher
Wiley
Online
2014-09-15
DOI
10.1002/phar.1488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of three generic vancomycin products using liquid chromatography-mass spectrometry and an online tool
- (2014) P. O. Lewis et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin
- (2014) Diane Cappelletty et al. CLINICAL DRUG INVESTIGATION
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam
- (2014) Lindsey D. Burgess et al. PHARMACOTHERAPY
- Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
- (2014) Diane M. Gomes et al. PHARMACOTHERAPY
- Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors
- (2014) Calvin J. Meaney et al. PHARMACOTHERAPY
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
- (2013) Michael N. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review
- (2013) P. Tattevin et al. CLINICAL INFECTIOUS DISEASES
- Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
- (2013) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with cefepime
- (2013) R.P. Moenster et al. CLINICAL MICROBIOLOGY AND INFECTION
- Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals
- (2013) Susan L. Davis et al. PHARMACOTHERAPY
- The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
- (2013) Jinjian Fu et al. PLoS One
- Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
- (2013) Ronald G Hall et al. BMC Pharmacology & Toxicology
- The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis
- (2012) Amy Horey et al. ANNALS OF PHARMACOTHERAPY
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
- (2012) S. J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits
- (2012) P. Tattevin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
- (2012) Yosuke Suzuki et al. CHEMOTHERAPY
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database
- (2012) Ennie L. Cano et al. CLINICAL THERAPEUTICS
- Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
- (2012) Sepideh Elyasi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of continuous infusion of vancomycin for the outpatient treatment of methicillin-resistant Staphylococcus aureus infections
- (2012) A. J. Verrall et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort
- (2012) Ravina Kullar et al. PHARMACOTHERAPY
- Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients
- (2011) Emi Minejima et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial
- (2011) John A. Bosso et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
- (2011) M. A. Cataldo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans
- (2011) Kavitha K. Prabaker et al. Journal of Hospital Medicine
- Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
- (2010) Lindsey Pritchard et al. AMERICAN JOURNAL OF MEDICINE
- Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
- (2010) Allan J. Walkey et al. CHEST
- ACUTE KIDNEY INJURY CLASSIFICATION
- (2010) Chih-Hsiang Chang et al. SHOCK
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Reduced Vancomycin Clearance Despite Unchanged Creatinine Clearance in Patients Treated With Vancomycin For Longer Than 4 Weeks
- (2009) Hirokazu Nakayama et al. THERAPEUTIC DRUG MONITORING
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The RIFLE criteria and mortality in acute kidney injury: A systematic review
- (2007) Z. Ricci et al. KIDNEY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now